Germany· DE-A57-c79b3c96acca0159
Nipruss
A medicinal product containing sodium nitroprusside dihydrate, registered in Germany by Altamedics Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Sodium Nitroprusside Dihydrate
- Manufacturer
- Altamedics Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium nitroprusside dihydrate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNIPRIDE RTUEXELA PHARMA SCIENCES, LLC
- United KingdomNitropress 50mg/2ml solution for infusion vialsImported (United States)
- CanadaNIPRIDEPFIZER CANADA ULC
- SpainNITROPRUSSIAT FIDES 50 MG POLVO PARA SOLUCION INYECTABLEViatris Healthcare Limited
- BelgiumNipruss 60 mgAltamedics
- IcelandNiprussOresund Pharma ApS
- NorwayNiprussOresund Pharma ApS
- SwedenNipruss 60 mg Pulver till infusionsvätska, lösningØresund Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Nipruss, Nitroprussid-Natrium Aftpharm
- Denmark · Nipruss
- Spain · Nitroprussiat Fides
- Finland · Nipruss
- United Kingdom (Northern Ireland) · Sodium Nitroprusside Aft Uk
- Hungary · Nipruss
- Iceland · Nipruss
- Netherlands · Nipruss
- Norway · Nipruss
- Sweden · Nipruss
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/35aa6330-40f0-428a-951c-5bdb5c16cc82 GET /v1/drugs/35aa6330-40f0-428a-951c-5bdb5c16cc82?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Sodium Nitroprusside Dihydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about sodium nitroprusside dihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.